Trial Profile
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, 2-Period, Crossover Study to Evaluate the Effects of a Single Dose of Montelukast on Exercise-Induced Bronchospasm
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Exercise-induced asthma
- Focus Therapeutic Use
- Sponsors Organon
- 22 Sep 2009 Actual patient number (40) added as reported by ClinicalTrials.gov.
- 22 Sep 2009 Trial phase changed from II/III to III as reported by ClinicalTrials.gov.
- 22 Sep 2009 Actual end date (Oct 2004) added as reported by ClinicalTrials.gov.